The landscape of dementia prognosis has developed significantly with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology a long time in advance of signs and symptoms emerge. When these technological advances symbolize amazing progress in comprehension neurode